Mainstay, the medical device maker, has had its plans to delist from the Dublin stock market approved by the High Court, ending its short life as a public company.
Mainstay has said that the delisting from Dublin, and also the Paris stock market, was down to the poor liquidity in its shares with very few actively traded, which depressed its value. The delisting means investors will receive one new share for every one they currently...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team